v3.26.1
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)
$ in Thousands
Total
Total RadNet, Inc.'s Equity
Common Stock
Common Stock
Equity Incentive Plan
Common Stock
DeepHealth, Inc.
Additional Paid-In Capital
Accumulated Other Comprehensive income (loss)
Accumulated Deficit
Noncontrolling Interests
Beginning balance (in shares) at Dec. 31, 2024     74,036,993            
Beginning balance at Dec. 31, 2024 $ 1,133,410 $ 902,308 $ 7     $ 988,147 $ (9,061) $ (76,785) $ 231,102
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Issuance of common stock upon exercise of options (in shares)     11,956            
Issuance of common stock upon exercise of options 121 121       121      
Issuance of common stock under the equity compensation plan (in shares)       906,835 3,438        
Stock-based compensation expense 28,514 28,514       28,514      
Forfeiture of restricted stock and share cancellation (in shares)     (2,656)            
Forfeiture of restricted stock and share cancellation (20) (20)       (20)      
Distributions paid to noncontrolling interests (913)               (913)
Change in cumulative foreign currency translation adjustment 4,109 4,109         4,109    
Change in fair value of cash flow hedge from prior periods reclassified to earnings 1,033 1,033         1,033    
Net (loss) income (29,737) (37,926)           (37,926) 8,189
Ending balance (in shares) at Mar. 31, 2025     74,956,566            
Ending balance at Mar. 31, 2025 $ 1,136,517 898,139 $ 7     1,016,762 (3,919) (114,711) 238,378
Beginning balance (in shares) at Dec. 31, 2025 77,399,615   77,399,615            
Beginning balance at Dec. 31, 2025 $ 1,355,886 1,089,890 $ 8     1,180,434 4,885 (95,437) 265,996
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Issuance of common stock upon exercise of options (in shares)     67,112            
Issuance of common stock upon exercise of options 103 103       103      
Issuance of common stock under the equity compensation plan (in shares)       892,960          
Stock-based compensation expense 31,440 31,440       31,440      
Forfeiture of restricted stock and share cancellation (in shares)     (4,774)            
Forfeiture of restricted stock and share cancellation (65) (65)       (65)      
Distributions paid to noncontrolling interests (2,402)               (2,402)
Issuance of common stock in connection with acquisitions (in shares)     190,924            
Issuance of common stock in connection with acquisitions 0 0       0      
Change in cumulative foreign currency translation adjustment (7,518) (7,351)         (7,351)   (167)
Net (loss) income $ (24,732) (33,466)           (33,466) 8,734
Ending balance (in shares) at Mar. 31, 2026 78,545,837   78,545,837            
Ending balance at Mar. 31, 2026 $ 1,352,712 $ 1,080,551 $ 8     $ 1,211,912 $ (2,466) $ (128,903) $ 272,161